This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring a pyrazine ring and an amine group, makes it a valuable intermediate in the creation of drugs targeting central nervous system disorders. It is often employed in the development of compounds with potential antipsychotic, antidepressant, or anxiolytic properties. Additionally, its chiral nature allows for the exploration of enantioselective drug actions, enhancing specificity and reducing side effects. Researchers also use it in the study of receptor interactions and enzyme inhibition, contributing to the discovery of novel therapeutic agents.